definiens inc cambridge
Prior to Veloxint Anna was a Director of Financial Planning & Analysis at Syneos Health. Seminar in Boston – Tissue Phenomics™ for Oncology Translational Sciences and Validation of The Immunoscore™ Register Now Here Date: Thursday, June 19, 2014 8:30am – 11:30am Location: Le Méridien Cambridge-MIT Hotel, Cambridge, MA Presenters: * Carlo Bifulco, M.D., Regional Laboratory, Earle A. Chiles Research Institute * Kristine Burke, Millennium Pharmaceuticals The … Tel. Singer, R. Khokha, L. P. Jones, J. M. Penninger. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Sharon is an advocate for financial literacy and her work has been featured nationally, including her two books, ON MY OWN TWO FEET: A Modern Girl’s Guide to Personal Finance and GET FINANCIALLY NAKED: How to Talk Money with your Honey. He has significant leadership experience across a broad range of life science businesses, including histology, proteomics and diagnostics. +1-617-945-2662 Join to Connect. See InSituPlex in action, no matter where you are. in Software Company, All Medical Companies, Oncology Company, Tissue / Wound Company. Ultivue and Definiens scientific teams will be present at their respective company booths #2048 and #2350 at the annual meeting of the American Association of Cancer Research (AACR), from March 29 through April 3, 2019 in Atlanta, Georgia. Most recently, Mark was instrumental in creating a diagnostic division for StatLab, launching a full portfolio of IHC reagents, automated staining platform as well as a patented reference standard control technology for tissue pathology. The joint offering will initially be based on the UltiMapper I/O PD-L1 and PD-1 kit panels and will further expand to a co-developed 8-plex IF immuno-oncology panel. Following residency and postdoc at Stanford, his lab at UT Southwestern characterized the Naked cuticle (Nkd) gene family as feedback regulators of Wnt-beta catenin signaling. For analysis of two-color IF stains and the blood vessel density of tissue slides stained by single-color IHC using an antibody against CD31, we used the Definiens Architect XD 2.1.1 with Tissue Studio (version 3.6.1; Definiens Inc., Cambridge, MA). Siobhan is a business-focused, results oriented executive with over 20 years of experience in diverse industries. Mike earned a BS in Microbiology and Cell Science and a PhD in Nucleic Acid Chemistry from the University of Florida, where he developed artificial genetic systems capable of replication and evolution. We support you with: Definiens, Inc. has not received any reviews. 2020 Ultivue, Inc. All rights reserved.For Research Use Only, not for use in diagnostic procedures. Munich, Bavaria (Germany) Munich, Bavaria (Germany) Munich, Bavaria (Germany) definiens is the world's leading provider of enterprise image intelligence solutions for earth observation/remote sensing and life sciences. Jacques also held commercial roles at LI-COR Biosciences and Roche Diagnostics. Department of Cellular and Molecular Medicine, Howard Hughes Medical Institute, University of California San Diego School of Medicine, La Jolla, CA 92037‐0686, USA. AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. Barry Lynch has been Vice President of Sales since September 2020. Assessment of Ki67 in breast tumors by DIA was a robust and quantitative method. Definiens Dicerna Pharmaceuticals Elemental Machines Eutropics Pharmaceuticals Excelimmune FogPharma Forrester Research Glympse Bio Genfit Genocea Biosciences ... Cambridge MedSpace Cellay, Inc. DropWise Technologies Factor Bioscience Fire Hose Games Geek Offices Industry Lab Novellus One Cell Systems, Inc. SECTOR. “We see great opportunities in expanding the existing IO-Panel solutions to IF. Learn More, We are changing the way providers access and engage customers to streamline the sale and delivery of R&D services. Since then, Definiens technology has been used in thousands of projects, yielding results that have accelerated drug development and produced over 650 peer-reviewed publications. The goal? Jobs. “Analysis of spatial relationships at cellular resolution with IF multiplexing will also add biological depth and context. We offer: Certainty is the hallmark of next-generation diagnostics. Over her 15 years with Sands Capital, assets under management grew from $1.5 billion to $50 billion. Definiens definition is - an expression that defines : definition. “Ultivue is excited to announce this first collaboration with Definiens that leverages the core competences and offerings of our respective organizations to deliver standardized multiplex staining, imaging and image analysis on FFPE tissue samples,” said Michael Natan, CEO, Ultivue. Definiens is the provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Siobhan holds a Master of Science in Human Resources and Adult Organizational Learning from Suffolk University as well as a Bachelor of Arts in English from Saint Anselm College. AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters in Cambridge, England. Definiens, Inc. - Definiens AG. Ultivue’s ability to provide kits paired with Definiens’ web-based analytics infrastructure will put the power of standardized IO profiling at the fingertips of researchers across the globe.”. K. Showler, M. Nishimura, K. Daino, T. Imaoka, Y. Nishimura, T. Morioka, B. J. Blyth, T. Kokubo, M. Takabatake, M. Fukuda, H. Moriyama, S. Kakinuma, M. Fukushi, Y. Shimada. Definiens has 47 employees. Results from this large prospective cohort study provide support for the clinical relevance of using Ki67 at the 14% cut point for luminal subtype classification and breast cancer prognosis. In 2013, Frost and Sullivan recognized Definiens as Company of the Year for Global Tissue Diagnostics and Pathology Imaging. Definiens is now an international company with over 100 employees worldwide, and headquartered in Munich, Germany and Cambridge, USA. Anna has nearly 20 years of finance experience in various positions across life sciences, technology, and advanced materials industries in public and venture capital-backed companies. a The word or words serving to define another word or expression, as in a dictionary entry. The collaboration will provide a standardized and scalable solution to enable access to IF multiplex immunohistochemistry (IHC) assays. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a … Fladd, T. D. McKee, Ch. Our precise quantitative biomarker readouts and best-in-class assay development in accordance with our certified quality management system, build certainty into your CDx. Where is Definiens headquarters? Definiens, The Tissue Phenomics Company | 3,773 followers on LinkedIn. This is the Definiens company profile. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. CAMBRIDGE, Mass. Anna holds an MBA degree from Carnegie Mellon University, Tepper School of Business and BA degree in Economics from Ben-Gurion University of the Negev. Leading Ultivue’s Assay Services Laboratory, he brings expertise in investigative pathology, multiplex microscopy and imaging, and digital pathology to our customers striving to realize the promise of personalized medicine. RANKL/RANK control Brca1 mutation-driven mammary tumors. Mike is a chemist/biologist with 15 years experience enabling innovative solutions in the biotechnology and diagnostics industries. Contact She is a leader who invests in designing & implementing successful HR strategies to create thriving, scalable cultures. To create new opportunities for discovery and advances in oncology and immuno-oncology. Read More . In 2013, Frost and Sullivan recognized Definiens as Company of the Year for Global Tissue Diagnostics and Pathology Imaging. He holds and honors degree in Biochemistry from the University of Dundee and a MSc in Biotechnology. Customized analysis of cell status, cell-to-cell dynamics and tissue context of biomarkers unlocks a deeper understanding of cancer. All content is posted anonymously by employees working at Definiens. Previously Mark held leadership roles in commercial development, Scientific Affairs and R&D at Enzo Lifesciences, Leica Biosystems NA (Danaher) and Novocastra Laboratories. Technology. The joint offering will comprehensively address clinical research and translational medicine market needs by combining Ultivue’s UltiMapper™ I/O kits and services with Definiens’ first in class digital image analysis, powered by Tissue Phenomics®, supported by leading machine learning technologies. Scientific expertise from board-certified pathologists and top experts in Tissue Phenomics, International regulatory knowledge for documentation and interactions with authorities, Agile project management in strategy planning and troubleshooting. contact@ultivue.com. T. P. Ahern, A. H. Beck, B. The Registered Agent on file for this company is Corporation Service Company and is located at 84 State St., Boston, MA 02109. Definiens, The Tissue Phenomics Company | 3.736 Follower auf LinkedIn We improve patient lives by unlocking the tissue phenome. AstraZeneca has a portfolio of products for major diseases including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas. Prior to joining Ultivue he was the Commercial Director (EMEA) with Advanced Cell Diagnostics. Competitors of Definiens include Cisbio, IMIDomics and Access Biologicals. Siobhan is responsible for leading the vision and development of the Human Resources strategy, including Talent Acquisition, Total Rewards, Leadership Development, Diversity and Engagement & Inclusion. Siobhan Desmond joined Ultivue in early 2021 as Head of People and Culture. Our scientific, regulatory and medical team support you throughout the process. Request a quote for more information about this service. View All. A. Rosner, B. ... VisioPharm, Definiens etc. V. Sigl, K. Owusu-Boaitey, P. A. Joshi, A. Kavirayani, G. Wirnsberger, M. Novatchkova, I. Kozieradzki, D. Schramek, N. Edokobi, J. Hersl, A. Sampson, A. Odai-Afotey, C. Lazaro, E. Gonzalez-Suarez, M. A. Pujana, for CIMBA, H. Heyn, E. Vidal, J. Cruickshank, H. Berman, R. Sarao, M. Ticevic, I. Uribesalgo, L. Tortola, S. Rao, Y. Tan, G. Pfeiler, E. YHP Lee, Z. Bago-Horvath, L. Kenner, H. Popper, Ch. Rent 24 Cellino Biotech Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from Upgrade Your Listing. Learn More, We improve patient lives by unlocking the tissue phenome. Cambridge, Massachusetts 500+ connections. Prior to Sands Capital, Sharon was a consultant at McKinsey & Company. For more information, visit www.ultivue.com. An intensional definition, also called a connotative definition, specifies the necessary and sufficient conditions for a thing to be a member of a specific set. Definiens Inc. is a Massachusetts Foreign Corporation filed On June 3, 2005. Definiens is now an international company with over 100 employees worldwide, and headquartered in Munich, Germany and Cambridge, USA. Using Tissue Phenomics, we mine data from your tissue samples to find meaningful signatures that link ‘omics data with clinical outcomes and generate insights beyond the scope of other approaches. Earlier in her career she held positions of increasing responsibility, including financial planning and analysis, manufacturing finance and accounting at Dolby Laboratories, Thermo Fisher Scientific and Pelephone Communications. Sharon is currently a board director at 908 Devices, Emulate, Isoplexis, Ultivue, and Vizgen. Louis Levy Recent Publications “Scientists taking advantage of the joint offering will be able to access comprehensive analyses of tumor microenvironment and immune cell phenotypes from their precious samples,” Natan added. Where are Definiens offices? Bookmark this | Send E-mail MassBio leverages its unparalleled network of innovative companies and industry thought leaders to advance policy and promote education, while providing member programs, events, industry information, and services. defining meaning: 1. present participle of define 2. to say what the meaning of something, especially a word, is: 3…. In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Sharon has an MBA from Harvard Business School and a BA in Economics from Rice University. Learn more. For Research Use Only. We are making R&D services readily available to every organization that seeks to make scientific impact. Improving Life. Who are Definiens competitors? Cambridge, MA. Our services include: Assessing the potential of a biomarker to identify patient populations requires correlating patient data with drug responses. Glass, G. Frieling, L. C. Collins, R. M. Tamimi. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms. DefiniGEN are a Cambridge UK company providing highly functional disease model human cells including hepatocytes, pancreatic beta cells and intestinal organoids SERVICES iPSC Differentiation Ultivue is based in Cambridge, MA. Not for use in diagnostic procedures. Mark Rees, PhD joined Ultivue’s executive team in January as Vice President of Corporate Development. Prior to Definiens, he was the Vice President of Sales at NanoString Technologies where he led the go-to-market strategy of the nCounter System. Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a pioneer in artificial intelligence (AI) based image analysis, today announced a collaboration to expand Definiens standardized IO-Panel capabilities to IF. A great place to work: Definiens Values. He was a NIH Ruth L. Kirschstein Postdoctoral Fellow at Harvard Medical School and a fellow at the Wyss Institute at Harvard where he developed multiplexed sequencing, in situ sequencing, and multiplexed synthetic biology technologies. She was previously CFO of Sands Capital Management. Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a pioneer in artificial intelligence (AI) based image analysis, today announced a collaboration to expand Definiens standardized IO-Panel capabilities to IF. Diagnostics, Definiens Inc., 125 Cambridge Park Drive Ste. : +1 858 534 7772; Fax: +1 858 534 7797; E-mail: [email protected] Network Sciences Inc., Cambridge, MA 02141, USA. Jobs; ... Cambridge, MA. She is a CFA charterholder. Most recently he was Chief Scientist/Head of Genomics R&D at Beckman Coulter Life Sciences and previously consulted in varying capacities for both established and startup biotechnology companies. Characterization of inflammatory cell patterns and densities using multiplex immunohistochemistry immuno-oncology assays [abstract]. The group, based at our Cambridge Innovation Center in Kendall Square, will work with internal and external partners to identify and deliver new novel therapies into patients at speed. Definiens headquarters is located at Bernhard-Wicki-Straße 5, München. • Cambridge Soft Corp • Cellectricon AB • Certara • ChanTest Corporation • Cmed Technology • Computype, Inc. • Convey Computers • CyVek Inc. • Decision View •Definiens Inc • Dell Inc • Elsevier • EMC Isilon • Enrich Consulting Inc • Epistem Ltd • Exostar LLC • Feeney Law Group (Fruent) • Google • Gyros, Inc. Definiens, Inc. has not received any endorsements. Services Offered: Analysis Remote Sensing Gis Earth Observation. The Data Incubator. Tel. By developing a single set of novel, proprietary reagents used both for biomarker discovery (higher content, low throughput) and translational use (lower content, high throughput), Ultivue is connecting the insights gained from research directly into the pathology lab. Definiens has offices in München and Cambridge. The company's filing status is listed as Withdrawal and its File Number is 000897576. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer. Sharon is Co-Founder, Partner of Northpond Ventures. Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay. Ultivue is expanding its UltiMapper assay product portfolio and menu of contract research services to provide a comprehensive set of precision medicine solutions for oncology research and focus in other therapeutic areas. She has advised on boards, such as Veritas Community School and is passionate about life long learning. The collaboration with Ultivue will enable us to provide IO profiles from a single tissue section – and we can use additional serial sections to investigate other relevant biomarkers,” said Thomas Heydler, CEO, Definiens. We quantify these features during assay development and the resulting insights drive confident pipeline decisions for clinical trials. Tissues were dehydrated, dried, and mounted with Cytoseal 60 (Thermo Scientific, Waltham, MA) and quantified and evaluated by Definiens Tissue Studio 64 [Dual] 4.1 with corresponding modules (Definiens, Inc., Cambridge, MA), ZEN 3.0 blue edition (Oberkochen, Germany) or … He brings extensive experience in nucleic acid chemistry/enzymology, in situ biomolecule detection, multiplexed biomolecule analysis, and sequencing system development. E. D. Hawkins, D. Duarte, O. Akinduro, R. A. Khorshed, D. Passaro, M. Nowicka, L. Straszkowski, M. K. Scott, S. Rothery, N. Ruivo, K. Foster, M. Waibel, R. W. Johnstone, S. J. Harrison, D. A. Westerman, H. Quach, J. Gribben, M. D. Robinson, L. E. Purton, D. Bonnet, C. L. Celso. Get info on this provider's capabilities without requesting a quote. A free inside look at Definiens offices and culture posted anonymously by employees. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. 15 Definiens office photos. 300, Cambridge, MA 02140, USA, Tel +1 (781) 859 8896, Email blaffin@definiens.com Received: June 01, 2017 | Published: June 14, 2017 Journal of Stem Cell Research & Therapeutics Mini Review Open Access For analysis of two-color IF stains and the blood vessel density of tissue slides stained by single-color IHC using an antibody against CD31, we used the Definiens Architect XD 2.1.1 with Tissue Studio (version 3.6.1; Definiens Inc., Cambridge, MA). Taking a ground-breaking technology that dramatically improves the information that can be extracted from histological images, Nobel Laureate Dr. Gerd Binnig founded Definiens in 1994. 125 Cambridge Park Drive, Suite 300 Cambridge, Massachusetts 02140 United States . Ultivue’s UltiMapper™ multiplexed assays applied to tissue biopsy samples enable simultaneous quantitation of multiple biomarkers with sub-cellular spatial resolution and fit completely within traditional IHC workflows. Our scientific and regulatory teams help design the best strategy to advance your prototype to regulatory filing and into the clinic. Definiens is now an international company with over 100 employees worldwide, and headquartered in Munich, Germany and Cambridge, USA. L. Hammoud, J. R. Adams, A. J. Loch, R. C. Marcellus, D. E. Uehling, A. Aman, Ch. Now offering virtual, remote, and in-person demos. Definiens Inc. Definiens Inc. was founded in 2006. Mark has 21+ years of leadership experience in Scientific Affairs and Business development within research and diagnostic markets. We improve patient lives by unlocking the tissue phenome. Keith is a board-certified anatomic pathologist with diverse achievements in research and drug/diagnostic development. and MUNICH, June 30, 2011 /PRNewswire/ -- Metamark Genetics, a privately-held oncology molecular diagnostic company, and Definiens, the leading Health Image Intelligence company, today announced a development and commercialization partnership in which Metamark will combine its proprietary multiplex protein detection platform with image analysis … Cambridge Soft Corp Carterra Cellecta Inc Cellectricon AB Celsee Diagnostics Certara Champions Oncology Inc Charles River Labs Cmed Technology Cofactor Genomics Computype, Inc. 1Definiens GmbH, Munich, Germany, 2Ultivue Inc, Cambridge, MA, USA, 3Royal Liverpool University Hospital, Liverpool, UK REFERENCES 1) Lisa M. Dauffenbach, et al. Learn More, We believe that good experiments can and should be independently replicated and validated. Case Western Reserve University. In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Translational and clinical researchers leverage UltiMapper assays to elucidate complex biology and demonstrate their clinical utility as precision medicine research tools. CAMBRIDGE, Mass – March 29, 2019. Cambridge, MA. Anna Pevzner is a Controller and Senior Director of Financial Planning & Analysis at Ultivue. Best Places to Work 2021 NEW! Become a Member. Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomas. The company's line of business includes the retail sale of computers, computer peripheral equipment, and software. E.B. Most recently he was Senior Medical Director of Leica Biosystems, and prior to that he led and supported R&D, toxicology, biomarker, and clinical study teams in multiple therapeutic areas at Novartis and Biogen. We never forget that behind every tissue and every slide, there is a patient with a story. He holds a PhD in Molecular Biology & Microbiology, MS in Industrial Microbiology and a BS (hons) in Biochemistry, graduating from Newcastle University Medical School, England UK. Cambridge, MA. CAMBRIDGE, Mass – March 29, 2019. Object-oriented Image Analysis Satellite Images Classification Image Processing. Jo, R. Al-Awar, S. E. Egan, J. Rossant. Copyright © 2021 Science Exchange, Inc. All rights reserved. Industry, Sector and Symbol. Most recently Anna led finance function at Veloxint, where she supported fundraising and oversaw planning and accounting for the MIT-incubated advanced materials startup. Glassdoor gives you an inside look at what it's like to work at Definiens, including salaries, reviews, office photos, and more. He earned a BS in Chemical Engineering from the University of Arizona, and MD and PhD in Molecular Biology from UCLA, where he discovered the molecular basis of DNA recognition by bHLH-PAS transcription factors. Barry began his career with Invitrogen in 1999 where he went on to lead commercial teams at the Europe and Asia Pacific regional level.